Sales rise 51.75% to Rs 273.81 crore
Net profit of Marksans Pharma rose 1285.29% to Rs 9.42 crore in the quarter ended September 2017 as against Rs 0.68 crore during the previous quarter ended September 2016. Sales rose 51.75% to Rs 273.81 crore in the quarter ended September 2017 as against Rs 180.43 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales273.81180.43 52 OPM %8.980.10 -PBDT21.555.82 270 PBT14.57-0.08 LP NP9.420.68 1285Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
